0.776
1.80%
-0.0142
Dopo l'orario di chiusura:
.77
-0.006
-0.77%
Omega Therapeutics Inc Azioni (OMGA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
138.62%
2.36
|
0.989 | 0.831 | 0.759 | 0.516 |
Operating Expenses
|
5.18%
22.81
|
21.69 | 23.73 | 31.60 | 26.33 |
Benefits Costs and Expenses |
6.07%
22.49
|
21.20 | - | - | 25.80 |
Costs And Expenses |
6.07%
22.49
|
21.20 | 23.73 | 31.60 | 25.80 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
1.20%
-20.45
|
-20.70 | -22.90 | -30.84 | -25.82 |
Net Interest Income/Expense |
32.03%
0.331
|
0.487 | 0.684 | 0.957 | 0.682 |
Nonoperating Income/Loss |
33.61%
0.322
|
0.485 | 0.655 | 1.153 | 0.539 |
Income/Loss From Continuing Operations Before Tax |
0.42%
-20.13
|
-20.21 | 0.831 | -29.69 | -25.28 |
Income/Loss From Continuing Operations After Tax |
0.42%
-20.13
|
-20.21 | -22.25 | -29.69 | -25.28 |
Net Income/Loss
|
0.42%
-20.13
|
-20.21 | -22.25 | -29.69 | -25.28 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
14,355%
55.15
|
0.3815 | 55.14 | 55.07 | 50.63 |
Diluted Average Shares |
14,355%
55.15
|
0.3815 | 55.14 | 55.07 | 50.63 |
Basic Earnings Per Share |
0.00%
-0.36
|
-0.36 | -0.40 | -0.54 | -0.50 |
Diluted Earnings Per Share |
0.00%
-0.36
|
-0.36 | -0.40 | -0.54 | -0.50 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):